Trump FDA Tackles Opioid Crisis With New Medication Approval
The U.S. Food and Drug Administration approved a new over-the-counter naloxone nasal spray on Tuesday in an effort to combat the nation’s opioid overdose crisis. Rextovy is a naloxone hydrochloride nasal spray that can be used for the emergency treatment of opioid overdoses, according to the FDA. The approval “aligns with President Donald Trump’s Great American Recovery Initiative, a federal effort…
